Fructose Metabolism Disorder Clinical Trial
Official title:
Effects of Low Fructose Diet on Glycemic Control in Patients With Type 2 Diabetes
Verified date | August 2017 |
Source | National Nutrition and Food Technology Institute |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Diabetes is one of the most common and chronic diseases in the world, with the prevalence and incidence of this disease rising in most societies, especially in Iran. Suitable treatments for type 2 diabetes include changing lifestyle with exercise, nutrition, and drug use. New research suggests that added sugar, especially fructose, is the main trigger for diabetes and pre-diabetes even more potent than other carbohydrates. Fructose has a low glycemic index (23μg =) and slowly increases blood glucose levels. Therefore, it is thought that replacing fructose instead of glucose can have a positive effect on glycemic control of diabetic patients..
Status | Active, not recruiting |
Enrollment | 48 |
Est. completion date | November 30, 2017 |
Est. primary completion date | October 1, 2017 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 40 Years to 70 Years |
Eligibility |
Inclusion Criteria: 1. Age of 70-40 years 2. body mass index(BMI) between 18.5 and 27 3. Type 2 diabetes People who only control their diabetes by using glucose lowering tablets Type 2 diabetes (1 to 10 years) Exclusion Criteria: 1. Pregnancy and lactation 2. Thyroid gland disorders 3. Kidney disease and inflammation 4. Follow the weight loss regimen 6 months before starting the study 5. Usage of fatty and fatty foods, fiber powder Vitamin A Mineral Supplements, Omega 3 6. Taking glucocorticoid drugs and non-steroidal anti-inflammatory drugs |
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
National Nutrition and Food Technology Institute |
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | fasting blood suger(FBS) | 8 weeks | ||
Primary | Homeostatic model assessment and insulin resistance(HOMA-IR) | 8weeks | ||
Primary | insulin | 8 weeks | ||
Secondary | Triglyceride | 8 weeks | ||
Secondary | Total cholestrole | 8 weeks | ||
Secondary | LDL-C | 8 weeks | ||
Secondary | HDL-C | 8 weeks | ||
Secondary | Blood pressure | 8 weeks |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03939130 -
Fructose Rich Diet and Endothelial Function
|
N/A | |
Active, not recruiting |
NCT05826717 -
Effect of Matrices on Serum Fructose.
|
N/A |